MedPath

KINERET

KINERET

Approved
DIN Number

02245913

Drug Class

Human

Market Date

May 29, 2002

Company
HC

Swedish Orphan Biovitrum AB (Publ)

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02245913
AIG Number0147441001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L04AC03 ANAKINRA
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.20.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

ANAKINRAActive
Strength: 150 MG / ML
Monograph: ANAKINRA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.